מכפיל מחיר להכנסות עתידי Lantheus Corp (LNTH)

A stable staff of radiologists and the motivation of R&D personnel create a foundation for the growth of Lantheus Holdings, Inc. (LNTH). However, reliance on imports from Asia and Europe leaves raw material logistics vulnerable to sanctions. The forward P/S metric captures these risks, where the parameter value equals 2.60. Meanwhile, global conflicts and the short shelf life of drugs limit the company's expansion into international markets.
Lantheus Holdings, Inc. (LNTH) - פילוחי מדדים ודוחות פיננסיים

Lantheus Holdings, Inc. (LNTH) controls a monopoly segment of radiopharmaceuticals, where the unique logistics of Pylarify and FDA protection guarantee exceptional clinic loyalty. This forward price-to-sales ratio chart correlates the company's market value with expected sales, allowing investors to conduct a real-time assessment of business stability and promptly identify either an undervalued asset or rising liquidity risks.